Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2012-04-13 Transaction in Own Shar…
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly details the weekly progress of a 'share buy-back programme,' reporting the number of shares bought back, the average transaction price, and the accumulated total. This activity falls directly under the definition of a company repurchasing its own shares. The relevant filing category is 'Transaction in Own Shares' (POS). The document length is short (2431 chars) and it is a direct report of the transaction data, not an announcement of a report's publication.
2012-04-13 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 98% confidence The document explicitly details the activity under a 'Share buy-back programme' for ALK-Abelló A/S, providing weekly accumulated data on the number of shares bought back and the total amount spent. This directly corresponds to the definition of a Transaction in Own Shares (POS), which covers share repurchase activities. The document is a specific report on this activity, not just an announcement of a report's publication.
2012-04-13 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text explicitly details a share buyback program ('aktietilbagekøbsprogram') initiated by ALK-Abelló A/S. It provides weekly transaction data (number of shares bought, average price, total amount in DKK) related to this program, which runs until April 30, 2012. The core subject is the company's transaction in its own shares (share repurchase). This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). The document is a specific report/update on this activity, not a general announcement of a report (RPA) or a general regulatory filing (RNS).
2012-04-10 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly details the ongoing activity of a 'share buy-back programme'. It reports the number of shares bought back on specific trading days and the accumulated total. This activity falls directly under the definition of a company repurchasing its own shares. The corresponding filing type is 'Transaction in Own Shares' (POS). The document is a direct report of the transaction activity, not an announcement of a report.
2012-04-10 English
Director's Dealing 2012
Director's Dealing
2012-03-30 Danish
Director's Dealing 2012
Director's Dealing
2012-03-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.